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Effect of biological activity of PTH on its peripheral metabolism in the
rat. Previous studies from our laboratory have characterized the
peripheral metabolism of parathyroid hormone (PTH) in the dog using
radioimmunoassay techniques following injection or infusion of biolog-
ically active, bovine PTH preparations. Other investigators have used
biologically—inactive labelled PTH and interpreted their results as
representative of the normal physiological processes. Since oxidized
inactive PTH does not bind to PTH receptors and since we have found
substantial differences between the tissue uptake of active and inactive
PTH preparations, it is possible that results obtained with inactive PTH
preparations may not totally represent the normal metabolism of PTH.
Therefore, we performed studies in rats to compare the disappearance
of immunoreactive PTH (i-PTH) from plasma following injection of
active or inactive syn b-PTH 1-34. The maneuvers of bilateral ureteral
ligation and bilateral nephrectomy were utilized to characterize the sites
of tissue uptake of i-PTH. The results obtained indicate that inactive
syn b-PTH 1-34 has a significantly slower disappearance from plasma
than biologically active syn b-PTH 1-34. Reduction of glomerular
filtration by acute bilateral ureteral ligation decreased the disappear-
ance of oxidized PTH more than active PTH. Thus, the results indicate
a major dependence on glomerular filtration for the removal of inactive
syn b-PTH 1-34. The demonstration that the peripheral metabolism of
active and inactive syn b-PTH 1-34 is not identical suggests that studies
of the metabolism of inactive PTH preparations do not accurately
reflect that of biologically active PTH.
Previous studies from our laboratory have described the
peripheral metabolism of parathyroid hormone in the dog and
characterized the sites of uptake of PTH [1—51. These studies
indicated that the liver and kidneys appeared to be the major
sites for removal of immunoreactive PTH (i-PTH) from the
circulation following administration of intact b-PTH 1-84. Fol-
lowing administration of syn b-PTH 1-34, the major sites of
removal of i-PTH from the circulation appeared to be bone and
the kidneys. While these studies utilized biologically—active
unlabelled PTH and radioimmunoassay techniques, other in-
vestigators have utilized biologically inactive, isotopically—
labelled PTH preparations and interpreted the results as the
normal physiological degradation process of PTH by peripheral
organs [6—8]. Since oxidized biologically—inactive PTH does not
bind to PTH receptors [9, 10], it is possible that results obtained
with inactive PTH preparations may not accurately reflect those
obtained with active PTH.
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The present studies were designed to identify sites of uptake
of immunoreactive PTH in the rat, comparing results obtained
with active and inactive synthetic b-PTH 1-34, to ascertain if
differences existed in the peripheral metabolism of biologically
active and inactive synthetic b-PTH 1-34.
Methods
The PTH preparation used in these studies was synthetic
b-PTH 1-34 purchased from Beckman Instruments (Palo Alto,
California, USA; claimed specific biological activity, 6800
lU/mg). For studies of biologically inactive syn b-PTH 1-34,
this peptide was inactivated by oxidation with hydrogen perox-
ide by incubation of 10 to 50 sg in 60 l of 0.15 M acetic acid
with 40 d of 30% hydrogen peroxide for 45 minutes at 37°C and
lyophilized. Inactivation of the b-PTH 1-34 was confirmed by
assay of adenylate cyclase activity in canine renal corti-
cal—membranes as previously described [11]. Syn b-PTH 1-34,
oxidized by the above procedure, routinely demonstrated a
greater than 95% reduction in biological activity and was used
within one week of preparation.
Studies of the disappearance rate of immunoreactive PTH
from blood were performed in Sprague—Dawley rats, 300 to 400
g body wt. The experimental animals were divided into three
groups: Group 1, normal rats; Group 3, rats one hour after
bilateral ureteral ligation; Group 3, rats one hour after bilateral
nephrectomy. The disappearance of i-PTH from blood was
measured in each group of rats by measurement of im-
munoreactive PTH in plasma 2, 20, 40 and 60 minutes after
bolus intravenous injection of either syn b-PTH 1-34 or oxidized
syn b-PTH 1-34 (25 jsg/kg body wt). Five rats from each group
received active PTH and five rats from each group received
oxidized PTH 1-34.
Rats with bilateral ureteral ligation, Group 2, allow the study
of the disappearance of i-PTH without influence of glomerular
filtration while renal blood flow is preserved. Thus, in this
animal preparation, PTH is delivered to the basolateral surface
of renal tubular cells, the site of receptors for PTH.
i-PTH was measured by radioimmunoassay using antiserum,
CH9N. This antiserum, produced against synthetic bPTH 1-34,
is specific for the amino—terminal region of the PTH molecule.
The assay procedure was similar to that described previously
[1] except that phase separation was achieved by second
antibody technique. The standard curves obtained in this assay
with syn b-PTH 1-34 and oxidized syn b-PTH 1-34 were
superimposable.
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Fig. 1. Disappearance of i-PTH from plasma following injection of
biologically active syn b-PTH 1-34 (•—•) and biologically inactive syn
b-PTH 1-34 in normal rats (•— —
—•). The vertical bars represent the
standard error of the mean.
Statistical analysis of the results from the different groups
was performed by analysis of variance for multiple groups.
Results
Studies in normal rats
Figure 1 illustrates the disappearance of i-PTH from blood in
normal rats following a single injection of active syn b-PTH 1-34
or biologically inactive syn b-PTH 1-34. The levels of i-PTH 40
and 60 minutes after injection were significantly higher in rats
receiving oxidized b-PTH 1-34 than in those receiving active
syn b-PTH 1-34 (P < 0.05).
Studies in rats with bilateral ureteral ligation
In this group of rats, the process of glomerular filtration is
markedly reduced while renal blood flow is preserved. Figure 2
illustrates that under these conditions the disappearance rate of
biologically inactive PTH is markedly prolonged compared to
that seen with biologically active PTH, as indicated by signifi-
cantly higher values for i-PTH at all time points after injection
in animals receiving oxidized syn b-PTH 1-34 (P < 0.01). The
difference between the disappearance of active and inactive
PTH preparations in these animals is greater than in Group 1
animals (P < 0.05).
Studies following bilateral nephrectomy
Following removal of the kidneys, the disappearance rate of
inactive PTH from the circulation appears to be markedly
prolonged compared to that of biologically active PTH as
shown in Figure 3 (P < 0.01). Studies in these animals should
Fig. 2. Disappearance of i-PTH from plasma following injection of
active (0—0) and inactive (0—— —0) syn b-PTH 1-34 in rats with
bilateral ureteral ligation. The vertical bars represent the standard error
of the mean.
reflect the absence of both delivery of PTH to receptor sites in
the kidney and the degradative process of glomerular filtration
and tubular reabsorption. Based upon previous studies the
major site of PTH uptake under these circumstances is the
skeleton [4].
Comparison between groups for active and inactive PTH
In order to compare the effects of removal of glomerular
filtration alone (but preservation of renal blood flow) and
elimination of both processes for renal uptake of i-PTH, Figure
4 illustrates the disappearance of i-PTH in the three study
groups for active (4A) and inactive PTH (4B).
In the studies using active PTH (4A) bilateral ureteral ligation
or bilateral nephrectomy results in significantly higher levels of
i-PTH in plasma compared to that of normal animals (P < 0.02)
(4B). Total removal of the kidneys is associated with higher
plasma levels of i-PTH than those in the ureterally obstructed
animals (P < 0.02).
In contrast, the Figure 4B illustrates the results obtained with
inactive b-PTH 1-34. The disappearance of i-PTH in Group 2
(bilateral ureteral ligation) and Group 3 (bilateral nephrectomy)
animals was identical (P = NS) and in both cases the disap-
pearance rate of i-PTH was significantly slower than in Group 1
(normal) animals (P < 0.01).
Discussion
The present studies were undertaken to examine the effects
of the biological activity of synthetic b-PTFI 1-34 on the
peripheral metabolism of i-PTH in the rat in vivo. The experi-
ments utilized the maneuver of acute ureteral ligation in order
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Fig. 3. Disappearance of i-PTH from plasma following injection of
active (A—A) and inactive (A---A) syn b-PTH 1-34 in bilaterally
nephrectomized rats. The vertical bars represent the standard error of
the mean.
to dissociate the two potential renal mechanisms for the metab-
olism of PTH, namely glomerular filtration and uptake at
peritubular sites which depends upon renal blood flow. Acute
ureteral ligation results in a marked decrease in glomerular
filtration rate while renal blood flow is preserved [2].
Based upon our previous studies in the dog the peripheral
metabolism of syn b-PTH 1-34 depends upon glomerular filtra-
tion, peritubular uptake and uptake of syn b-PTH 1-34 by the
skeleton [5]. Thus, in the present studies, the prolongation of
the disappearance rate for i-PTH by ureteral obstruction as
indicated by the higher levels of i-PTH in plasma is consistent
with the role of glomerular filtration in the removal of PTH from
the circulation. The further prolongation of the disappearance
rate of i-PTH following removal of the kidneys illustrates the
importance of the role of peritubular uptake in PTH uptake in
the rat, again consistent with the data obtained in the dog [2].
In the studies with inactive b-PTH 1-34 interesting differences
in the results are observed. Since oxidized PTH has been shown
not to bind to PTH receptors in kidney [12, 13], and is not
extracted by the skeleton in the dog [4], it would be anticipated
that the disappearance of inactive syn b-PTH 1-34 should
depend upon glomerular filtration and not upon peritubular
uptake nor skeletal uptake. Previous studies by Kao and Maack
in the isolated perfused kidney using inactive labeled PTH also
found that the renal handling of oxidized PTH was solely
dependent upon glomerular filtration [14]. Thus, the results
show that ureteral obstruction results in a marked prolongation
of the disappearance rate of i-PTH, indicating the major role of
glomerular filtration in the metabolism of PTH. However, total
removal of the kidney did not alter this further. Thus, these data
are consistent with the lack of a peritubular uptake mechanism
for oxidized inactive PTH.
In the nephrectomized rat, the major site of uptake of syn
b-PTH 1-34 appears to be the skeleton. The results show that
the disappearance of inactive PTH is markedly prolonged in
bilaterally nephrectomized rats compared to that of active PTH
as indicated by the significantly higher plasma levels of i-PTH in
the nephrectomized group. These data reflect the uptake of
i-PTH by the skeleton and are consistent with the lack of uptake
of inactivated syn b-PTH 1-34 by the skeleton.
The present studies do not address the role of the liver in the
removal of immunoreactive PTH from the circulation. Previous
studies from our laboratory in the dog have indicated that this
organ does not appear to play a role in the removal of i-PTH
following injection of syn b-PTH 1-34 [3]. However, recent
studies by d'Amour et a! using biologically—inactive radiolabel-
led PTH and unlabelled syn b-PTH 1-34 suggest that some
metabolism of PTH 1-34 may occur in the liver with the release
of fragments of b-PTH 1-34 [8]. Thus, it is possible that there
may appear to be net extraction of i-PTH by the liver if these
fragments do not react in the particular immunoassay used. The
studies of Bergeron et al in the rat suggest that there is binding
of a PTH 1-34 analog in the liver although no data of net
extraction were presented [15]. Thus, it is possible that the liver
may contribute to the clearance of i-PTH following administra-
tion of PTH 1-34 in the rat. Further studies are required to
clarify the role of the liver in the metabolism of PTH 1-34 in the
rat.
In summary, these studies of the disappearance of i-PTH
from plasma following injection of syn b-PTH 1-34 or oxidized
syn b-PTH 1-34 demonstrate major differences in the peripheral
metabolism of the two peptides. Thus, studies of the peripheral
metabolism of PTH using biologically inactive preparations of
PTH may not be analogous to the results obtained using bio-
logically active PTH.
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Fig. 4. A. Comparison of the disappearance of i-PTH from plasma
following injection of active syn b-PTH 1-34 in normal rats (—S), rats
with bilateral ureteral ligation (0—0) and bilaterally nephrectomized
rats (A—A). B. Comparison of the disappearance of i-PTH from plasma
following injection of inactive syn b-PTH 1-34 in normal rats (— —
—•),
rats with bilateral ureteral ligation (0—0) and bilaterally nephrecto-
mized rats (A— — —A). The vertical bars represent the standard error of
the mean.
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